A novel technique that uses a magnetically guided gel to seal off a part of the heart could one day lower stroke risk for millions of people with atrial fibrillation. The experimental approach, which has shown success in animal studies, aims to permanently close a small pouch where dangerous blood clots often form.
Atrial fibrillation causes the heart's upper chambers to beat chaotically, which can allow blood to pool and clot in a structure called the left atrial appendage. If a clot escapes, it can travel to the brain and cause a stroke, making patients with this condition about five times more likely to suffer one. Current primary treatments involve lifelong anticoagulant drugs, which carry a risk of serious bleeding, or implanting a rigid metal device to plug the appendage, which can sometimes incompletely seal the irregularly shaped space.
The new method takes a different path. Doctors would inject a magnetically responsive liquid directly into the appendage via a catheter. An external magnetic field then holds the fluid in place as it solidifies into a soft gel within minutes, conforming perfectly to the unique shape of the pouch. This magnetogel creates a seal, and the heart's inner lining eventually grows over it, forming a smooth surface designed to prevent clot formation. In studies using pigs, whose hearts are similar to humans, the gel remained stable for 10 months without leakage or clotting and avoided the tissue damage sometimes caused by rigid implants.
Researchers caution that the technology is years away from clinical use. Significant hurdles remain, including ensuring long-term safety, refining the delivery procedure, and addressing practical issues like the gel's interference with MRI scans. Further testing in larger animals is required before human trials can be considered.
If these challenges are met, the injectable gel could offer a valuable alternative for patients who cannot tolerate blood thinners, potentially providing a more adaptable and complete seal than current devices. For a condition affecting tens of millions globally, this innovation represents a hopeful step toward more effective and personalized stroke prevention.